A Randomized, Placebo-Controlled Study of Outpatient Premedication for Bone Marrow Biopsy in Adults with Lymphoma

Alexandra P. Wolanskyj, Georgene Schroeder, Peter R. Wilson, Thomas Matthew Habermann, David J. Inwards, Thomas Elmer Witzig

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

The outpatient bone marrow biopsy and aspiration (BMBA) procedure performed with local anesthetic is often poorly tolerated in adults. This prospective, randomized, placebo-controlled, double-blind trial was designed to determine whether oral (p.o.) lorazepam and hydromorphone reduces pain and anxiety during BMBA. Eligible patients had lymphoma, had no prior BMBA, and were ≥ 18 years old. Since patients had bilateral BMBA, each served as their own control. Patients were stratified by anxiety level using the Spielberger Trait Anxiety Scale and randomized to: A) placebo for the first BMBA and 2 mg lorazepam and 2 mg hydromorphone p.o. for the contralateral BMBA, or B) placebo for both BMBAS. Changes in pain and anxiety experienced between the first and second BMBA were measured by the Visual Analogue Scale (VAS) and the Spielberger State Anxiety Scale at the time of the BMBA and 24 hours later. Twenty-seven patients were enrolled and 25 were evaluable; there were 17 males and eight females. The median age was 57 years (range, 28-79 years). Overall, BMBA was reported as painful in both arms, with a median VAS pain score after the second BMBA of 3.9 (scale, 0-10) for arm A and 5.8 for arm B (P= 0.21). There was no difference in the change in pain, anxiety, or recalled anxiety between treatment arms (all P values > 0.05). The difference in the change in recalled pain was of borderline significance (P = 0.07) and consistent with benzodiazepine-induced anterograde amnesia.

Original languageEnglish (US)
Pages (from-to)154-157
Number of pages4
JournalClinical Lymphoma
Volume1
Issue number2
StatePublished - Sep 2000

Fingerprint

Premedication
Needle Biopsy
Lymphoma
Outpatients
Bone Marrow
Placebos
Biopsy
Anxiety
Hydromorphone
Lorazepam
Pain
Anterograde Amnesia
Pain Measurement
Local Anesthetics
Benzodiazepines
Visual Analog Scale

Keywords

  • Analgesia
  • Bone marrow biopsy
  • Pain

ASJC Scopus subject areas

  • Cancer Research

Cite this

A Randomized, Placebo-Controlled Study of Outpatient Premedication for Bone Marrow Biopsy in Adults with Lymphoma. / Wolanskyj, Alexandra P.; Schroeder, Georgene; Wilson, Peter R.; Habermann, Thomas Matthew; Inwards, David J.; Witzig, Thomas Elmer.

In: Clinical Lymphoma, Vol. 1, No. 2, 09.2000, p. 154-157.

Research output: Contribution to journalArticle

Wolanskyj, Alexandra P. ; Schroeder, Georgene ; Wilson, Peter R. ; Habermann, Thomas Matthew ; Inwards, David J. ; Witzig, Thomas Elmer. / A Randomized, Placebo-Controlled Study of Outpatient Premedication for Bone Marrow Biopsy in Adults with Lymphoma. In: Clinical Lymphoma. 2000 ; Vol. 1, No. 2. pp. 154-157.
@article{7b5f193599234912b670a27e6db5d1df,
title = "A Randomized, Placebo-Controlled Study of Outpatient Premedication for Bone Marrow Biopsy in Adults with Lymphoma",
abstract = "The outpatient bone marrow biopsy and aspiration (BMBA) procedure performed with local anesthetic is often poorly tolerated in adults. This prospective, randomized, placebo-controlled, double-blind trial was designed to determine whether oral (p.o.) lorazepam and hydromorphone reduces pain and anxiety during BMBA. Eligible patients had lymphoma, had no prior BMBA, and were ≥ 18 years old. Since patients had bilateral BMBA, each served as their own control. Patients were stratified by anxiety level using the Spielberger Trait Anxiety Scale and randomized to: A) placebo for the first BMBA and 2 mg lorazepam and 2 mg hydromorphone p.o. for the contralateral BMBA, or B) placebo for both BMBAS. Changes in pain and anxiety experienced between the first and second BMBA were measured by the Visual Analogue Scale (VAS) and the Spielberger State Anxiety Scale at the time of the BMBA and 24 hours later. Twenty-seven patients were enrolled and 25 were evaluable; there were 17 males and eight females. The median age was 57 years (range, 28-79 years). Overall, BMBA was reported as painful in both arms, with a median VAS pain score after the second BMBA of 3.9 (scale, 0-10) for arm A and 5.8 for arm B (P= 0.21). There was no difference in the change in pain, anxiety, or recalled anxiety between treatment arms (all P values > 0.05). The difference in the change in recalled pain was of borderline significance (P = 0.07) and consistent with benzodiazepine-induced anterograde amnesia.",
keywords = "Analgesia, Bone marrow biopsy, Pain",
author = "Wolanskyj, {Alexandra P.} and Georgene Schroeder and Wilson, {Peter R.} and Habermann, {Thomas Matthew} and Inwards, {David J.} and Witzig, {Thomas Elmer}",
year = "2000",
month = "9",
language = "English (US)",
volume = "1",
pages = "154--157",
journal = "Clinical Lymphoma, Myeloma and Leukemia",
issn = "2152-2669",
publisher = "Cancer Media Group",
number = "2",

}

TY - JOUR

T1 - A Randomized, Placebo-Controlled Study of Outpatient Premedication for Bone Marrow Biopsy in Adults with Lymphoma

AU - Wolanskyj, Alexandra P.

AU - Schroeder, Georgene

AU - Wilson, Peter R.

AU - Habermann, Thomas Matthew

AU - Inwards, David J.

AU - Witzig, Thomas Elmer

PY - 2000/9

Y1 - 2000/9

N2 - The outpatient bone marrow biopsy and aspiration (BMBA) procedure performed with local anesthetic is often poorly tolerated in adults. This prospective, randomized, placebo-controlled, double-blind trial was designed to determine whether oral (p.o.) lorazepam and hydromorphone reduces pain and anxiety during BMBA. Eligible patients had lymphoma, had no prior BMBA, and were ≥ 18 years old. Since patients had bilateral BMBA, each served as their own control. Patients were stratified by anxiety level using the Spielberger Trait Anxiety Scale and randomized to: A) placebo for the first BMBA and 2 mg lorazepam and 2 mg hydromorphone p.o. for the contralateral BMBA, or B) placebo for both BMBAS. Changes in pain and anxiety experienced between the first and second BMBA were measured by the Visual Analogue Scale (VAS) and the Spielberger State Anxiety Scale at the time of the BMBA and 24 hours later. Twenty-seven patients were enrolled and 25 were evaluable; there were 17 males and eight females. The median age was 57 years (range, 28-79 years). Overall, BMBA was reported as painful in both arms, with a median VAS pain score after the second BMBA of 3.9 (scale, 0-10) for arm A and 5.8 for arm B (P= 0.21). There was no difference in the change in pain, anxiety, or recalled anxiety between treatment arms (all P values > 0.05). The difference in the change in recalled pain was of borderline significance (P = 0.07) and consistent with benzodiazepine-induced anterograde amnesia.

AB - The outpatient bone marrow biopsy and aspiration (BMBA) procedure performed with local anesthetic is often poorly tolerated in adults. This prospective, randomized, placebo-controlled, double-blind trial was designed to determine whether oral (p.o.) lorazepam and hydromorphone reduces pain and anxiety during BMBA. Eligible patients had lymphoma, had no prior BMBA, and were ≥ 18 years old. Since patients had bilateral BMBA, each served as their own control. Patients were stratified by anxiety level using the Spielberger Trait Anxiety Scale and randomized to: A) placebo for the first BMBA and 2 mg lorazepam and 2 mg hydromorphone p.o. for the contralateral BMBA, or B) placebo for both BMBAS. Changes in pain and anxiety experienced between the first and second BMBA were measured by the Visual Analogue Scale (VAS) and the Spielberger State Anxiety Scale at the time of the BMBA and 24 hours later. Twenty-seven patients were enrolled and 25 were evaluable; there were 17 males and eight females. The median age was 57 years (range, 28-79 years). Overall, BMBA was reported as painful in both arms, with a median VAS pain score after the second BMBA of 3.9 (scale, 0-10) for arm A and 5.8 for arm B (P= 0.21). There was no difference in the change in pain, anxiety, or recalled anxiety between treatment arms (all P values > 0.05). The difference in the change in recalled pain was of borderline significance (P = 0.07) and consistent with benzodiazepine-induced anterograde amnesia.

KW - Analgesia

KW - Bone marrow biopsy

KW - Pain

UR - http://www.scopus.com/inward/record.url?scp=0034279037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034279037&partnerID=8YFLogxK

M3 - Article

VL - 1

SP - 154

EP - 157

JO - Clinical Lymphoma, Myeloma and Leukemia

JF - Clinical Lymphoma, Myeloma and Leukemia

SN - 2152-2669

IS - 2

ER -